Related Experiment Video
Updated: Jun 11, 2026

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy
Published on: August 9, 2024
Is there a role for routinely screening children with autism spectrum disorder for creatine deficiency syndrome?
Lv Wang1, Manya T Angley, Michael J Sorich
1Sansom Institute, University of South Australia, Adelaide, South Australia, Australia.
Insights
This study investigated if urinary creatine and guanidinoacetate levels could identify autism spectrum disorder (ASD) subtypes. Researchers found no significant differences, suggesting creatine deficiency syndrome is rare in ASD populations.
Area of Science:
- Biochemistry
- Neurodevelopmental Disorders
- Metabolic Disorders
Background:
- Autism spectrum disorder (ASD) is diagnosed behaviorally, lacking laboratory tests.
- Creatine deficiency syndrome (CDS) shares clinical features with ASD.
- Urinary creatine (CR) and guanidinoacetate (GAA) are potential biomarkers for CDS.
Purpose of the Study:
- To determine if screening for urinary CR and GAA levels can identify a subgroup of children with ASD.
- To explore the potential for dietary interventions in identified subgroups.
Main Methods:
- Collected morning urine samples from children with and without ASD.
- Analyzed urine samples for CR and GAA levels, normalized to creatinine.
- Compared CR:creatinine and GAA:creatinine ratios between ASD and control groups.
Main Results:
- No statistically significant differences were observed in urinary CR:creatinine or GAA:creatinine between children with ASD and controls.
- This indicates that CDS is likely a rare condition within the studied ASD cohort.
Conclusions:
- Routine screening for abnormal urinary CR and GAA is not supported by this study for the general ASD population.
- While CDS may present similarly to ASD, its prevalence in ASD cohorts appears to be low.
Abstract:
Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder that presents in the first three years of life. Currently, diagnosis of ASD is based on its behavioural manifestations, as laboratory diagnostic tests do not exist. Creatine deficiency syndrome (CDS) is one form of inborn error of metabolism where affected individuals have similar clinical features to individuals with ASD. Abnormal urinary creatine (CR) and guanidinoacetate (GAA) levels have been reported as biomarkers of CDS. We hypothesized that screening for abnormal levels of urinary CR and GAA in children with ASD may assist in identifying a subgroup of ASD individuals who can be managed with dietary interventions. Morning urine samples were collected from children with and without autism and analyzed for CR and GAA levels. Results showed there was no statistically significant difference in urinary CR:creatinine and GAA:creatinine between the children with ASD and sibling or unrelated controls. In conclusion, routine screening for abnormal urinary CR and GAA could be considered in ASD diagnostic protocols; however, individuals positive for CDS are likely to be rare in an ASD cohort.
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
